Wuhan, China

Bin He

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Hubei Wudang Animal Pharmaceutical Co., Ltd., Wuhan Academy of Agricultural Sciences. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bin He. Retrieved from https://idiyas.com/inventor/bin-he-oulnz9gb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bin He - Innovator in Pharmaceutical Preparations

Introduction

Bin He is a notable inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceutical preparations, particularly through his innovative work on arctigenin liquid nano-preparation.

Latest Patents

Bin He holds a patent for an arctigenin liquid nano-preparation and its preparation method. This patent provides a novel approach to creating a liquid nano-preparation of arctigenin, which is known for its advantages such as a nanoscale droplet diameter, significantly increased specific surface area, rapid absorption, and high bioavailability. The nano-preparation can be effectively captured by wandering leucocytes, allowing for targeted drug delivery to inflammatory lesions through chemiotaxis.

Career Highlights

Throughout his career, Bin He has worked with esteemed organizations such as the Wuhan Academy of Agricultural Sciences and Hubei Wudang Animal Pharmaceutical Co., Ltd. His work has been instrumental in advancing pharmaceutical technologies and improving therapeutic outcomes.

Collaborations

Bin He has collaborated with notable colleagues, including Lijun Wu and Zheng Lu, contributing to various projects in the field of pharmaceutical preparations.

Conclusion

Bin He is a distinguished inventor whose work in arctigenin liquid nano-preparation showcases his commitment to advancing pharmaceutical science. His innovative approaches have the potential to enhance targeted drug delivery and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…